455 related articles for article (PubMed ID: 9927293)
1. Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system.
Peters J; Obermüller N; Woyth A; Peters B; Maser-Gluth C; Kränzlin B; Gretz N
Endocrinology; 1999 Feb; 140(2):675-82. PubMed ID: 9927293
[TBL] [Abstract][Full Text] [Related]
2. Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats.
Volpe M; Gigante B; Enea I; Porcellini A; Russo R; Lee MA; Magri P; Condorelli G; Savoia C; Lindpaintner K; Rubattu S
Circ Res; 1997 Nov; 81(5):857-64. PubMed ID: 9351460
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
[TBL] [Abstract][Full Text] [Related]
4. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Mackie FE; Meyer TW; Campbell DJ
Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
[TBL] [Abstract][Full Text] [Related]
5. Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.
Kim S; Tokuyama M; Hosoi M; Yamamoto K
Hypertension; 1992 Sep; 20(3):280-91. PubMed ID: 1516946
[TBL] [Abstract][Full Text] [Related]
6. In situ demonstration of angiotensin-dependent and independent pathways for hyperaldosteronism during chronic extracellular fluid volume depletion.
Takaya J; Matsusaka T; Katori H; Tamura M; Miyazaki Y; Homma T; Ichikawa I
Mol Endocrinol; 2001 Dec; 15(12):2229-35. PubMed ID: 11731622
[TBL] [Abstract][Full Text] [Related]
7. Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor.
Zou LX; Imig JD; Hymel A; Navar LG
Am J Hypertens; 1998 May; 11(5):570-8. PubMed ID: 9633793
[TBL] [Abstract][Full Text] [Related]
8. Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen2)27.
Tokita Y; Franco-Saenz R; Mulrow PJ; Ganten D
Endocrinology; 1994 Jan; 134(1):253-7. PubMed ID: 8275941
[TBL] [Abstract][Full Text] [Related]
9. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
10. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats.
Roesch DM; Tian Y; Zheng W; Shi M; Verbalis JG; Sandberg K
Endocrinology; 2000 Dec; 141(12):4629-36. PubMed ID: 11108277
[TBL] [Abstract][Full Text] [Related]
11. The effect of losartan on potassium-stimulated aldosterone secretion in vitro.
Chiou CY; Kifor I; Moore TJ; Williams GH
Endocrinology; 1994 Jun; 134(6):2371-5. PubMed ID: 8194463
[TBL] [Abstract][Full Text] [Related]
12. A role for the adrenal renin-angiotensin system in the regulation of potassium-stimulated aldosterone production.
Nakamaru M; Misono KS; Naruse M; Workman RJ; Inagami T
Endocrinology; 1985 Nov; 117(5):1772-8. PubMed ID: 3899615
[TBL] [Abstract][Full Text] [Related]
13. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
14. A new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor-mediated modulation of nociception.
Pelegrini-da-Silva A; Martins AR; Prado WA
Neuroscience; 2005; 132(2):453-63. PubMed ID: 15802196
[TBL] [Abstract][Full Text] [Related]
15. Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors.
Gigante B; Rubattu S; Russo R; Porcellini A; Enea I; De Paolis P; Savoia C; Natale A; Piras O; Volpe M
Hypertension; 1997 Sep; 30(3 Pt 2):563-8. PubMed ID: 9322982
[TBL] [Abstract][Full Text] [Related]
16. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
[TBL] [Abstract][Full Text] [Related]
17. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
Gonçalves AR; Fujihara CK; Mattar AL; Malheiros DM; Noronha Ide L; de Nucci G; Zatz R
Am J Physiol Renal Physiol; 2004 May; 286(5):F945-54. PubMed ID: 15075190
[TBL] [Abstract][Full Text] [Related]
18. Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat.
Ortega A; Rámila D; Izquierdo A; González L; Barat A; Gazapo R; Bosch RJ; Esbrit P
J Am Soc Nephrol; 2005 Apr; 16(4):939-49. PubMed ID: 15728788
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the renin-angiotensin system may alter the adrenocortical regeneration.
Zieleniewski W
Cytobios; 2001; 104(406):127-32. PubMed ID: 11258541
[TBL] [Abstract][Full Text] [Related]
20. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.
Neves MF; Virdis A; Schiffrin EL
J Hypertens; 2003 Jan; 21(1):189-98. PubMed ID: 12544451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]